vs

Side-by-side financial comparison of Axon Enterprise (AXON) and Chime Financial, Inc. (CHYM). Click either name above to swap in a different company.

Axon Enterprise is the larger business by last-quarter revenue ($807.3M vs $543.5M, roughly 1.5× Chime Financial, Inc.). Axon Enterprise runs the higher net margin — 21.0% vs -10.1%, a 31.0% gap on every dollar of revenue. On growth, Axon Enterprise posted the faster year-over-year revenue change (33.7% vs 28.8%).

Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.

Chime Financial, Inc. is an American financial technology company based in San Francisco, California. It provides fee-free mobile banking services through two national banks, Stride Bank and The Bancorp Bank.

AXON vs CHYM — Head-to-Head

Bigger by revenue
AXON
AXON
1.5× larger
AXON
$807.3M
$543.5M
CHYM
Growing faster (revenue YoY)
AXON
AXON
+4.9% gap
AXON
33.7%
28.8%
CHYM
Higher net margin
AXON
AXON
31.0% more per $
AXON
21.0%
-10.1%
CHYM

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
AXON
AXON
CHYM
CHYM
Revenue
$807.3M
$543.5M
Net Profit
$169.3M
$-54.7M
Gross Margin
59.1%
87.2%
Operating Margin
44.5%
-11.9%
Net Margin
21.0%
-10.1%
Revenue YoY
33.7%
28.8%
Net Profit YoY
-148.4%
EPS (diluted)
$2.05
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXON
AXON
CHYM
CHYM
Q1 26
$807.3M
Q4 25
$796.7M
Q3 25
$710.6M
$543.5M
Q2 25
$668.5M
$528.1M
Q1 25
$603.6M
Q4 24
$573.4M
Q3 24
$544.3M
$421.9M
Q2 24
$504.1M
$384.2M
Net Profit
AXON
AXON
CHYM
CHYM
Q1 26
$169.3M
Q4 25
$2.7M
Q3 25
$-2.2M
$-54.7M
Q2 25
$36.1M
$-923.4M
Q1 25
$88.0M
Q4 24
$136.0M
Q3 24
$67.0M
$-22.0M
Q2 24
$40.8M
$385.0K
Gross Margin
AXON
AXON
CHYM
CHYM
Q1 26
59.1%
Q4 25
57.9%
Q3 25
60.1%
87.2%
Q2 25
60.4%
87.3%
Q1 25
60.6%
Q4 24
60.5%
Q3 24
60.8%
87.3%
Q2 24
60.3%
86.9%
Operating Margin
AXON
AXON
CHYM
CHYM
Q1 26
44.5%
Q4 25
-6.3%
Q3 25
-0.3%
-11.9%
Q2 25
-0.2%
-176.2%
Q1 25
-1.5%
Q4 24
-2.6%
Q3 24
4.4%
-7.3%
Q2 24
6.5%
-2.5%
Net Margin
AXON
AXON
CHYM
CHYM
Q1 26
21.0%
Q4 25
0.3%
Q3 25
-0.3%
-10.1%
Q2 25
5.4%
-174.8%
Q1 25
14.6%
Q4 24
23.7%
Q3 24
12.3%
-5.2%
Q2 24
8.1%
0.1%
EPS (diluted)
AXON
AXON
CHYM
CHYM
Q1 26
$2.05
Q4 25
$0.02
Q3 25
$-0.03
$-0.15
Q2 25
$0.44
$-7.29
Q1 25
$1.08
Q4 24
$1.68
Q3 24
$0.86
$-0.34
Q2 24
$0.53
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXON
AXON
CHYM
CHYM
Cash + ST InvestmentsLiquidity on hand
$718.9M
$445.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.5B
$1.4B
Total Assets
$7.1B
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXON
AXON
CHYM
CHYM
Q1 26
$718.9M
Q4 25
$1.7B
Q3 25
$2.4B
$445.0M
Q2 25
$2.1B
$868.3M
Q1 25
$2.2B
Q4 24
$788.1M
Q3 24
$1.0B
$270.8M
Q2 24
$968.9M
$295.4M
Total Debt
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
$1.8B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$680.3M
Q3 24
Q2 24
Stockholders' Equity
AXON
AXON
CHYM
CHYM
Q1 26
$3.5B
Q4 25
$3.2B
Q3 25
$3.0B
$1.4B
Q2 25
$2.7B
$1.4B
Q1 25
$2.6B
Q4 24
$2.3B
Q3 24
$2.1B
$-1.9B
Q2 24
$1.9B
$-1.9B
Total Assets
AXON
AXON
CHYM
CHYM
Q1 26
$7.1B
Q4 25
$7.0B
Q3 25
$6.7B
$2.0B
Q2 25
$6.2B
$1.9B
Q1 25
$6.1B
Q4 24
$4.5B
Q3 24
$4.0B
Q2 24
$3.7B
Debt / Equity
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
0.56×
Q3 25
0.66×
Q2 25
0.73×
Q1 25
0.79×
Q4 24
0.29×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXON
AXON
CHYM
CHYM
Operating Cash FlowLast quarter
$17.5M
Free Cash FlowOCF − Capex
$15.4M
FCF MarginFCF / Revenue
2.8%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
$217.2M
Q3 25
$60.0M
$17.5M
Q2 25
$-91.7M
$2.7M
Q1 25
$25.8M
Q4 24
$250.2M
Q3 24
$91.3M
Q2 24
$82.8M
Free Cash Flow
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
$155.4M
Q3 25
$33.4M
$15.4M
Q2 25
$-114.7M
$-888.0K
Q1 25
$932.0K
Q4 24
$225.4M
Q3 24
$64.8M
Q2 24
$71.4M
FCF Margin
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
19.5%
Q3 25
4.7%
2.8%
Q2 25
-17.2%
-0.2%
Q1 25
0.2%
Q4 24
39.3%
Q3 24
11.9%
Q2 24
14.2%
Capex Intensity
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
7.8%
Q3 25
3.7%
0.4%
Q2 25
3.4%
0.7%
Q1 25
4.1%
Q4 24
4.3%
Q3 24
4.9%
Q2 24
2.2%
Cash Conversion
AXON
AXON
CHYM
CHYM
Q1 26
Q4 25
79.14×
Q3 25
Q2 25
-2.54×
Q1 25
0.29×
Q4 24
1.84×
Q3 24
1.36×
Q2 24
2.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXON
AXON

Segment breakdown not available.

CHYM
CHYM

Payments Revenue$363.2M67%
Platform Related Revenue$180.4M33%

Related Comparisons